Xofigo (radium Ra 223) for Treatment of Patients with Castration-Resistant Prostate Cancer - 102164

Spotlight
Video

Xofigo (radium Ra 223) for Treatment of Patients with Castration-Resistant Prostate Cancer

Loading........
Description: Mark Rutstein, Vice President of Oncology Development of Bayer discusses the xofigo injection, a treatment method for patients with castration-resistant prostate cancer, symptomatic bone metastases, and no known visceral metastatic disease. This was recorded at the 2017 ASCO Annual Meeting in Chicago, IL.
Shared By : AnnualMeeting2017
Posted on : 06/02/17
Added : 11 months ago
Category : Prostate Cancer